ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: SA-PO731

Clinical Outcomes of Patients Receiving Long-Term Continuous Ambulatory Peritoneal Dialysis for More Than 10 Years

Session Information

  • Peritoneal Dialysis - II
    November 04, 2017 | Location: Hall H, Morial Convention Center
    Abstract Time: 10:00 AM - 10:00 AM

Category: Dialysis

  • 608 Peritoneal Dialysis

Authors

  • Kang, Seong Sik, Keimyung University School of Medicine, Daegu, Korea (the Republic of)
  • Park, Hayeon, Keimyung University School of Medicine, Daegu, Korea (the Republic of)
  • Yeo, Sang Mok, Keimyung University School of Medicine, Daegu, Korea (the Republic of)
  • Park, Woo Yeong, Keimyung University School of Medicine, Daegu, Korea (the Republic of)
  • Jin, Kyubok, Keimyung University School of Medicine, Daegu, Korea (the Republic of)
  • Park, Sung Bae, Keimyung University School of Medicine, Daegu, Korea (the Republic of)
  • Han, Seungyeup, Keimyung University School of Medicine, Daegu, Korea (the Republic of)
Background

The penetration of peritoneal dialysis (PD) is decreasing lately as it is difficult to keep it stable for a long time due to infectious or non-infectious complications. However, PD is still an important and physiologic modality of dialysis for end-stage renal disease. Our objective is to analyze the characteristics of patients who are safely maintaining PD for long period.

Methods

We retrospectively investigated 78 patients who had performed PD over 10 years. We analyzed the characteristics of patients, the episodes of PD peritonitis, the change of laboratory findings between the beginning of PD and 10 years after PD, and patient survival.

Results

The mean duration of PD was 152 ± 26.6 months. The mean age at which dialysis began was 46 ± 12 years. The mean number of peritonitis episodes was 0.228 times/patient/year. The mean time from the beginning of PD to first episode of PD peritonitis was 57 ± 51.9 months. Patient survival was 100% at 10 year, 63.7% at 15 year, 45.2% at 20 year, and the leading cause of death was infection (16.7%), followed by cardiovascular disease (3.8%). There were no changes of level of serum albumin, TG, LDL, HDL, and CRP between basal and 10 year follow-up result. Nutritional status, inflammation markers, and chronic kidney disease-mineral bone disease were well maintained compared with overall PD population.

Conclusion

In the long-term PD patients, the mean age at which dialysis began was younger and the mean time to occur first peritonitis was longer, compared with the previous reported studies. It means long-term PD patients had attack of PD peritonitis less and late and maintained good nutrition status and iron, calcium and phosphorus balance for long time. We should pay more attention to maintain good nutritional status and low incidence of PD peritonitis for maintenance of long-term PD.